These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 520746)

  • 21. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
    Lekieffre J; Vaur L; Kacet S; Lacroix D
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
    Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
    Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.
    Arakawa M; Miwa H; Noda T; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):253-9. PubMed ID: 8314654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the treatment of cardiac arrhythmias with Palpitin.
    Oźarek-Medyńska T; Krynicki M; Polubiec A
    Ther Hung; 1990; 38(1):26-9. PubMed ID: 2111940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.